CareDx (NASDAQ: CDNA) revenue
CareDx reported revenue of $379.8m for fiscal 2025, 13.8% more than in fiscal 2024 ($333.8m). Since fiscal 2016 its revenue has grown by 834.8%, an average growth of 28.2% a year.
CareDx has grown its revenue for 2 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2023, −12.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $379.8m | +13.8% | −$30.8m | −8.1% |
| 2024 | $333.8m | +19.1% | $40.8m | 12.2% |
| 2023 | $280.3m | −12.9% | −$203.4m | −72.5% |
| 2022 | $321.8m | +8.6% | −$77.2m | −24.0% |
| 2021 | $296.4m | +54.2% | −$29.7m | −10.0% |
| 2020 | $192.2m | +51.3% | −$22.5m | −11.7% |
| 2019 | $127.1m | +66.0% | −$24.5m | −19.3% |
| 2018 | $76.6m | +58.4% | −$15.6m | −20.3% |
| 2017 | $48.3m | +18.9% | −$20.3m | −42.0% |
| 2016 | $40.6m | — | −$37.3m | −91.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
CareDx revenue compared with its sector
By revenue for its latest fiscal year, CareDx ranks 208th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; CareDx, 13.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 206th | Krystal Biotech | $389.1m | 33.9% |
| 207th | Sonida Senior Living | $381.1m | 25.2% |
| 208th | CareDx | $379.8m | 13.8% |
| 209th | Twist Bioscience | $376.6m | 20.3% |
| 210th | Arcutis Biotherapeutics | $376.1m | 91.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of CareDx
- How much revenue did CareDx make in fiscal 2025?
- CareDx reported revenue of $379.8m for fiscal 2025, compared with $333.8m in fiscal 2024.
- How much has the revenue of CareDx grown?
- Between fiscal 2016 and fiscal 2025 it went from $40.6m to $379.8m: 834.8% more, an average growth of 28.2% a year.
- What was the best year for revenue at CareDx?
- Of its last 10 fiscal years, fiscal 2025, with $379.8m.
- Where does CareDx rank in its sector by revenue?
- It ranks 208th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for CareDx come from?
- From the annual report (Form 10-K) that CareDx files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that CareDx files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on CareDx: the CareDx page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.